1.It had to happen sooner or later. Goldman Sachs (GS) downgraded shares of Advanced Micro Devices (AMD) and set a sharply lower price target. I have a $15+ PT on AMD, based on Ryzen 5 and 7 sales, the release of Vega, and continued revenue growth from Polaris.2.Novavax (NVAX) had its usual sell-off day. The stock is now $0.90. Any stock below $1.00 is subject to delisting. Beware.3.Synergy Pharmaceuticals (SGYP) is now sharply below my $4.50-$4.75 entry price. SGYP issued an sNDA two weeks ago. On no news, the drop in the shares is odd. Are you buying the dip?4.Watch Rite Aid (RAD). Fred’s willingness to buy some stores raises the odds of the WBA-RAD deal happening5.As usual, Plug Power (PLUG) dipped after a massive run-up the day before. Be careful with holding PLUG.6.Nvidia (NVDA) is fighting the $100/sh level. I suspect more downside ahead as analysts are indiscriminately downgrading high-flying stocks.7.Snapchat (SNAP) drifts lower and lower. A breach below $20 will happen.8.Watch basic materials. AKS, CLF, FCX, VALE, BHP, RIO are the ones to watch. More infrastructure spend means more revenue for these companies.|